Iron Deficiency in Heart Failure and Effect of Dapagliflozin: Findings From DAPA-HF

Iron deficiency is common in heart failure and associated with worse outcomes. We examined the prevalence and consequences of iron deficiency in the DAPA-HF trial (Dapagliflozin and Prevention of Adverse-Outcomes in Heart Failure) and the effect of dapagliflozin on markers of iron metabolism. We als...

Descripción completa

Detalles Bibliográficos
Autores principales: Docherty, Kieran F., Welsh, Paul, Verma, Subodh, De Boer, Rudolf A., O’Meara, Eileen, Bengtsson, Olof, Køber, Lars, Kosiborod, Mikhail N., Hammarstedt, Ann, Langkilde, Anna Maria, Lindholm, Daniel, Little, Dustin J., Sjöstrand, Mikaela, Martinez, Felipe A., Ponikowski, Piotr, Sabatine, Marc S., Morrow, David A., Schou, Morten, Solomon, Scott D., Sattar, Naveed, Jhund, Pardeep S., McMurray, John J.V.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2022
Materias:
Original Research Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9508991/
https://www.ncbi.nlm.nih.gov/pubmed/35971840
http://dx.doi.org/10.1161/CIRCULATIONAHA.122.060511

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9508991/
https://www.ncbi.nlm.nih.gov/pubmed/35971840
http://dx.doi.org/10.1161/CIRCULATIONAHA.122.060511

Ejemplares similares